|
Relative risks, 95% confidence intervals and associated p-values for the most common cancers observed in the study and for those cancers commonly found in FA homozygotes. |
|||||
| Cancer |
Observed |
Expected |
O/E |
95% C.I. |
p-value |
|
|
|||||
| Breast |
7 |
8.97 |
0.78 |
0.31–1.59 |
0.795 |
| Lung |
9 |
9.3 |
0.97 |
0.44–1.84 |
0.583 |
| Colorectal |
6 |
7.1 |
0.85 |
0.51–3.04 |
0.264 |
| Prostate |
5 |
3 |
1.66 |
0.54–3.89 |
0.185 |
| Stomach |
3 |
2.98 |
1.01 |
0.21–2.94 |
0.573 |
| Endometrial |
3 |
1.41 |
2.13 |
0.44–6.2 |
0.168 |
| Leukaemia |
2 |
1.29 |
1.55 |
0.19–5.6 |
0.370 |
| Head and Neck |
3 |
1.59 |
1.89 |
0.12–15.9 |
0.214 |
| ALL CANCERS |
55 |
56.95 |
0.97 |
0.71–1.23 |
0.62 |
|
O/E = observed versus expected, C.I. = confidence interval | |||||
Tischkowitz et al. BMC Cancer 2008 8:257 doi:10.1186/1471-2407-8-257 |
|||||